Home / Drug shortages / Meperidine Hydrochloride Injection

Meperidine Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Meperidine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 05/30/2025.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6053-25
Dosage Form
Injection
Presentation
Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25)
Initial Posting
05/30/2025
Revised Date

FDA data resources